How HIV and drug use affect other health conditions
Comorbidities and other consequences at the intersection of the HIV and substance use epidemics
This project looks at how methamphetamine, cocaine, and opioid use affect health, treatment, and other conditions for people living with HIV, especially those with unstable housing, recent incarceration, or little social support.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11118862 on NIH RePORTER |
What this research studies
If you join, researchers will ask about the types, frequency, and ways you use drugs, any overdoses, and access to naloxone. They will gather information on your HIV care, other health problems like diabetes, housing status, incarceration history, social support, and experiences of stigma. The team will combine surveys, medical records, and biological or behavioral measures recommended by community partners to find patterns in use and health outcomes across different groups. The aim is to use these findings to shape better treatments, prevention, and support services for people living with HIV.
Who could benefit from this research
Good fit: People living with HIV who use methamphetamine, cocaine, or opioids — especially those with unstable housing, recent incarceration, limited social support, or HIV-related stigma — are the best fit for this work.
Not a fit: People who do not have HIV or who do not use these substances are unlikely to benefit directly from this project.
Why it matters
Potential benefit: Could lead to more tailored treatments and support that reduce drug-related harms and improve HIV and chronic disease care for affected people.
How similar studies have performed: Previous observational studies have linked substance use to worse HIV outcomes and informed interventions, but combining multiple drugs and focusing on vulnerable subgroups is less well studied.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Crane, Heidi M. — University of Washington
- Study coordinator: Crane, Heidi M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.